Venkatadri
Bobba joins Cancer Genetics India’s Board of Directors
Bobba has over 36 years of
corporate leadership experience in the pharma and life sciences industries
Cancer Genetics, provider
of DNA-based cancer diagnostics, has announced the addition of Venkatadri Bobba
to Cancer Genetics India’s Board of Directors.
“Bobba has a tremendous
track record of leadership in the life sciences. His experiences and insights
will bring significant value to CG India’s board of directors,” said Panna
Sharma, CEO and President of Cancer Genetics.
Bobba has over 36 years of
corporate leadership experience in the pharma and life sciences industries,
informs a company release. Bobba, who is currently a General Partner with
Ventureast, has held executive leadership positions at a number of life
sciences companies in the US, EU, and Asia. Prior to joining Ventureast, Bobba
served as Senior VP of Operations at Aradigm Corporation and from 2001-2003 was
Executive Vice President at Diosynth, a division of Akzo Nobel. From 1995 to
2000, Bobba served as President and CEO at Molecular Biosystems. Previous to
that, Bobba was Executive Vice President of Centocor Inc (now Jansen Biotech, a
division of Johnson & Johnson) and held several executive positions,
including President, at Warner-Lambert, Indonesia. He also previously served as
VP of Manufacturing at Parke-Davis, US (now part of Pfizer).
It is an exciting time to
be part of such a high-growth market like India. I look forward to the growth
and much needed innovation that CG India will bring to Indian cancer patients
and hospitals at an affordable price,” said Bobba. “CG India has established
itself as a leader in the oncology diagnostics market with a firm commitment to
innovation. I look forward to helping the company offer novel cancer diagnostic
tests to all patients who needs them to improve their clinical outcomes.”
Bobba is an active board
member of three US-based companies, including Diabetomics, Melior Pharma, and
Sparsha. Bobba also sits on the board of several Indian-based companies,
including Portea, Richcore, and Sparsha Pharma, an Indian subsidiary of Napo
Pharmaceuticals. Additionally, he serves on the advisory board for the SOHO
Group, the largest pharma company in Indonesia, and for Cumberland
Pharmaceuticals.
A pharmacist by training,
Bobba graduated with gold medal honors from Andhra University and holds an MBA
from Farleigh Dickinson University, New Jersey.
No comments:
Post a Comment